Modern Biological Theories of Aging

Modern Biological Theories of Aging

Aging Dis. 2010 October 1; 1(2): 72–74.

Kunlin Jin, Aging and Disease, 8001 Redwood, Blvd. Novato, California 94945, USA;

Abstract

Despite recent advances in molecular biology and genetics, the mysteries that control human lifespan are yet to be unraveled. Many theories, which fall into two main categories: programmed and error theories, have been proposed to explain the process of aging, but neither of them appears to be fully satisfactory. These theories may interact with each other in a complex way. By understanding and testing the existing and new aging theories, it may be possible to promote successful aging.

Why do we age? When do we start aging? What is the aging marker? Is there a limit to how old we can grow? These questions are often pondered by the mankind in the past couple of hundred years. However, in spite of recent advances in molecular biology and genetics, the mysteries that control human lifespan are yet to be unraveled.

Many theories have been proposed to explain the process of aging, but neither of them appears to be fully satisfactory (1). The traditional aging theories hold that aging is not an adaptation or genetically programmed. Modern biological theories of aging in humans fall into two main categories: programmed and damage or error theories. The programmed theories imply that aging follows a biological timetable, perhaps a continuation of the one that regulates childhood growth and development. This regulation would depend on changes in gene expression that affect the systems responsible for maintenance, repair and defense responses. The damage or error theories emphasize environmental assaults to living organisms that induce cumulative damage at various levels as the cause of aging.

The programmed theory has three sub-categories: 1) Programmed Longevity. Aging is the result of a sequential switching on and off of certain genes, with senescence being defined as the time when age-associated deficits are manifested. Dr. Davidovic et al discuss the role of genetic instability in aging and dynamics of the aging process (1). 2) Endocrine Theory. Biological clocks act through hormones to control the pace of aging. Recent studies confirm that aging is hormonally regulated and that the evolutionarily conserved insulin/IGF-1 signaling (IIS) pathway plays a key role in the hormonal regulation of aging. Dr. van Heemst discusses the potential mechanism underlying IIS and aging process(2). 3) Immunological Theory. The immune system is programmed to decline over time, which leads to an increased vulnerability to infectious disease and thus aging and death. It is well documented that the effectiveness of the immune system peaks at puberty and gradually declines thereafter with advance in age. For example, as one grows older, antibodies lose their effectiveness, and fewer new diseases can be combated effectively by the body, which causes cellular stress and eventual death (3). Indeed, dysregulated immune response has been linked to cardiovascular disease, inflammation, Alzheimer’s disease (AD), and cancer. Although direct causal relationships have not been established for all these detrimental outcomes, the immune system has been at least indirectly implicated (4).

The damage or error theory include 1) Wear and tear theory. Cells and tissues have vital parts that wear out resulting in aging. Like components of an aging car, parts of the body eventually wear out from repeated use, killing them and then the body. So the wear and tear theory of aging was first introduced by Dr. August Weismann, a German biologist, in 1882, it sounds perfectly reasonable to many people even today, because this is what happens to most familiar things around them. 2) Rate of living theory. The greater an organism’s rate of oxygen basal metabolism, the shorter its life span (5). The rate-of-living theory of aging while helpful is not completely adequate in explaining the maximum life span (6). Dr. Rollo proposes a modified version of Pearl’s rate of living theory emphasizing the hard-wired antagonism of growth (TOR) and stress resistance (FOXO) (7). 3) Cross-linking theory. The cross-linking theory of aging was proposed by Johan Bjorksten in 1942 (8). According to this theory, an accumulation of cross-linked proteins damages cells and tissues, slowing down bodily processes resulting in aging. Recent studies show that cross-linking reactions are involved in the age related changes in the studied proteins (9). 4) Free radicals theory. This theory, which was first introduced by Dr. Gerschman in 1954, but was developed by Dr. Denham Harman (10, 11), proposes that superoxide and other free radicals cause damage to the macromolecular components of the cell, giving rise to accumulated damage causing cells, and eventually organs, to stop functioning. The macromolecules such as nucleic acids, lipids, sugars, and proteins are susceptible to free radical attack. Nucleic acids can get additional base or sugar group; break in a single- and double-strand fashion in the backbone and cross link to other molecules. The body does possess some natural antioxidants in the form of enzymes, which help to curb the dangerous build-up of these free radicals, without which cellular death rates would be greatly increased, and subsequent life expectancies would decrease. This theory has been bolstered by experiments in which rodents fed antioxidants achieved greater mean longevity. However, at present there are some experimental findings which are not agreed with this early proposal. The review by Igor Afanas’ev shows that reactive oxygen species (ROS) signaling is probably the most important enzyme/gene pathway responsible for the development of cell senescence and organismal aging and that ROS signaling might be considered as further development of free radical theory of aging (12). 5) Somatic DNA damage theory. DNA damages occur continuously in cells of living organisms. While most of these damages are repaired, some accumulate, as the DNA Polymerases and other repair mechanisms cannot correct defects as fast as they are apparently produced. In particular, there is evidence for DNA damage accumulation in non-dividing cells of mammals. Genetic mutations occur and accumulate with increasing age, causing cells to deteriorate and malfunction. In particular, damage to mitochondrial DNA might lead to mitochondrial dysfunction. Therefore, aging results from damage to the genetic integrity of the body’s cells.

Since the 1930s, it has been found that restricting calories can extend lifespan in laboratory animals (13). Many studies were performed to try to elucidate the underlying mechanisms. However, our knowledge remains limited at the genetic and molecular levels until 1990 (14). Recently, Michael Ristow’s group has provided evidence that this effect is due to increased formation of free radicals within the mitochondria causing a secondary induction of increased antioxidant defense capacity (15). In this special issue, Dr. Shimokawa and Dr. Trindade discuss recent findings on restricting calories-related genes or molecules in rodent models, particularly on the roles of fork head box O transcription factors, AMP-activated protein kinase, and sirtuins (particularly SIRT1) in the effects of restricting calories in rodents (14).

Some neurological diseases are considered to be at high risk with increasing age, for example, AD, which is diagnosed in people over 65 years of age. Discovery of molecular basis of the processes involved in their pathology or creating and studying aging model systems may help our better understanding the aging processing. In the early stages, the most commonly recognized symptom of AD is inability to acquire new memories. Recent studies show that endogenous neural stem cells in the hippocampus of adult brain may involve in memory function (16). Consistently, neural stem cell function in the hippocampus decreases with increased aging (17), but the reasons are still unclear. It is well-known that telomere maintenance appears to be essential for the prolonged persistence of stem cell function in organs with extensive cell turnover (18). In 1961, Dr. Hayflick theorized that the human cells ability to divide is limited to approximately 50-times, after which they simply stop dividing (the Hayflick limit theory of aging) (19). According to telomere theory, telomeres have experimentally been shown to shorten with each successive cell division (20). Certain cells, such as egg and sperm cells, use telomerase to restore telomeres to the end of their chromosome, insuring that cells can continue to reproduce and promote the survival of the species. But most adult cells lack this capacity. When the telomeres reach a critical length, the cell stops replicating at an appreciable rate, and so it dies off, which eventually leads to the death of the entire organism. Telomerase cannot completely prevent telomere shortening after extensive stem cell division either, providing a putative mechanism for the timely limit of stem cell replicative history and subsequent progressive decay in the maintenance of organ homeostasis at old ages (18, 21). A recent study shows that telomeres shorten with age in neural stem cells of the hippocampus and that telomerase-deficient mice exhibit reduced neurogenesis as well as impaired neuronal differentiation and neuritogenesis (22). Taken together, these findings indicate the link among brain aging, neural stem cells and neurological diseases. Dr. Taupin discusses the association of aging with neurogenesis by emphasizing the role of adult neurogenesis in the pathogenesis of neurological diseases (23).

Overall, while multiple theories of aging have been proposed, currently there is no consensus on this issue. Many of the proposed theories interact with each other in a complex way. By understanding and testing the existing and new aging theories, it may be possible to promote successful aging as well as to enhance the lifespan of mankind.

Bookmark and Share

Introduction To The Best Anti-Aging Herbs

Herbs can be some of your best allies for minimizing the health risks that come with age. Here are some expert suggestions for strengthening and healing major body systems.

You’ve gotten over the shock of your fortieth birthday—-maybe way over it. You’ve come to accept changes in your mind and body. Your skin is wrinkling, that spare tire won’t go away, you forget the occasional name. The circles under your eyes are getting darker, your hair grayer. Sound familiar?

Aging involves our whole being—it’s a biological, physical, psychological and cultural process. According to some inherent genetic code, our cellular processes have started to decline. Our immune system has become less efficient. The connective tissue in our skin produces more collagen than elastin, so the tissue is less pliable. Free radicals are taking their toll on various cell and organ systems. Whatever is happening, it happens to the best of us.

Continue reading

Bookmark and Share

Age Reversal with Alkaline Water

We live in a century of highly accelerated advancements in science and technology. At the turn of the century, man began to fly. Today, we can even fly to the moon. Isn’t it reasonable to expect that science today should discover the technology of reverse aging? Well, it has! This series of articles is to explain scientifically the simple truth about the process of aging, how to combat the aging process and going further, how to attempt to reverse aging.

Here is the simple process of aging. Every living cell within our body creates waste products. The nutrients from our food are delivered to each cell and they burn with oxygen to provide energy for us to live. The burned nutrients are the waste products. Whether you eat gourmet or junk food, all food generates waste products. The food that is either good or bad for you is determined by the amount and quality of the wastes produced: toxic, acid, alkaline, etc. Most of our cells go through metabolism and old dead cells become waste products.

These waste products must be discharged from our body. In fact, our body tries its best to dispose of them through urine and perspiration. Virtually all waste products are acidic; that is why urine is acidic and skin surface is also acidic. The problem is that, due to several reasons, our body cannot get rid of 100% of the waste products it produces.

The main reason for this is our life style. We stay up late and get up early. We do not take time to rest; some of us work more than one job. We, therefore, spend more time producing waste products than processing and discharging them.

The second reason is food. Most of the food we like is mainly acidic. Acidic food does not necessarily mean that it tastes acidic, but that the wastes it produces are acidic. Grains and meats are mainly acidic; fruits and vegetables are alkaline. Citric fruits may taste acidic but they are considered to be alkaline because they contain alkaline minerals.

The third reason is our environment. More healthy cells are killed by air, water and soil pollution than the natural death of cells caused by normal metabolism. Thus, more waste products are created.

The question is: “What happens to those non-disposed acidic waste products?” The answer is simple. These waste products become solid wastes, such as, cholesterol, fatty acid, uric acid, kidney stones, urates, phosphates, sulfates, etc., and, unknown to us, they accumulate and build-up somewhere within our body. This accumulation of non-disposed acidic wastes within our body is the aging process .

Alkaline neutralizes acid. Drinking alkaline water helps our body dissolve acid wastes and make it easier for the body to dispose of them safely. Since the accumulation of acid wastes is aging, the reduction of acid wastes is reverse aging. Alkaline water is not a medicine to cure any disease. However, if consumed regularly, alkaline water gradually reduces the accumulated acid wastes. As a result of acid reduction, there are many reports of natural health improvement in Japan.

We use alkaline soap to wash acidic dirt accumulated on our skin; we must wash the acidic dirt accumulated within our body by using alkaline water. Alkaline water has been available in Asia for over 30 years (2) ; water ionizers to produce alkaline water have been approved by Japanese government agencies as medical devices.

Bookmark and Share

Parthenogenesis: a new paradigm for regenerative and stem cell therapy?

Parthenogenesis is a form of asexual reproduction found in females, where growth and development of embryos occurs without fertilization by a male. In plants, parthenogenesis means development of an embryo from an unfertilized egg cell, and is a component process of apomixis. The offspring produced by parthenogenesis are always female in species that use the XY sex-determination system, and male in those that use the ZW sex-determination system. Parthenogenesis (<Gr. “virgin birth”) is production of offspring by a female with no genetic contribution from a male and without meiotic chromosome reduction. The process is common reproductive strategy among insects such as aphids, flies, ants, and honeybees, but is also known to occur in vertebrates including lizards, snakes, fish, birds, and amphibians.

Continue reading

Bookmark and Share

Conquering Aging with Cloning

Life Extension Interviews Michael West on new breakthroughs in anti-aging cloning research

Cloning: The word sounds like science fiction. But cloning is now science fact for many species, and it could hold the answer for the majority of problems of aging humans. Recent advances in cloning have come with remarkable speed, but doubts about their applicability to aging have remained. Now, in a major new paper published in the April 28, 2000 issue of the journal Science, a group led by Dr. Michael West has reported what may be the most revolutionary advance in cloning research so far. They have found that cloning can totally reverse cellular aging. To give you the inside story of this breakthrough, and on how it fits in with prospects for using cloning to intervene in aging, Gregory Fahy, Ph.D. and Saul Kent, President and founder of the Life Extension Foundation, interviewed Dr. West by telephone on March 18th, 2000. Dr. West is the founder of Geron. He is currently President and CEO of Advanced Cell Technology in Worcester, Massachusetts, where the research reported in Science was conducted.

Life Extension (LEF): Let’s start at the beginning. Given that you left Geron to pursue cloning opportunities with Advanced Cell Technology (ACT), cloning obviously must be pretty important. But what is cloning?
Mike West: Cloning, as it is used in popular language, means the process we call nuclear transfer, which is an asexual way of reproducing an animal. Rather than using a sperm and an egg cell and getting a genetic mix between two animals, making a unique offspring, cloning uses an egg cell which is stripped of its DNA and a cell from the body of an existing animal. That body (somatic) cell is then placed into the egg cell.

LEF: The whole cell is placed in the egg cell?
West: Yes. This is the step we call nuclear transfer.

LEF: Even though it’s more than the nucleus.
West: Yes. What we typically do is take the whole somatic cell and transfer it into an egg cell whose DNA has been removed. The result is a cell that has all of the DNA from an existing animal, so the resulting embryo and then, eventually, the animal is genetically identical to the original animal from which the cell was taken, unlike normal sexual reproduction, which leads to a unique new animal. In a sense it is being born again. It’s a rebirth of a genetically identical copy of the original animal.

LEF: Are there different ways of doing cloning? Does it matter what the source of the cells is for example?
West: The technology has really only been used in a somewhat widespread manner over the last five years or so. So there hasn’t been, to my knowledge, a complete survey of all of the different kinds of cells in the body from which we could clone an animal. But we do know that it is possible to clone an animal from cells that are usually easily accessible, such as skin cells or mucosal epithelial cells from the inside of the cheek.

LEF: How could cloning impact the field of anti-aging medicine?
West: Well, in the course of human aging, we have damage to the tissues and the cells in our body, not completely unlike the damage you see to your automobile over time. So, just like your carburetor needs to be replaced at some point, or your spark plugs need to be replaced, just through wear and tear you have organs that need to be replaced. I guess a striking example would be something like the loss of a tooth because of falling off a bicycle in a cross country race. Or a skin burn or other trauma. Also, of course, you can have an infectious disease, like a kidney infection which can damage the kidneys. Since the kidneys will not regenerate, they need to be replaced. So over the course of aging, we may need to have cells and/or tissues and organs replaced.

LEF: What is therapeutic human cloning?
West: Therapeutic human cloning is cloning for the possibility of recreating young cells and tissues (potentially of any kind) genetically identical to the person who needs them in order to replace worn out cells and tissues.

LEF: I think we need to clarify that when you are talking about therapeutic human cloning, we are now changing the definition of cloning that you gave us earlier. We are not talking about growing say a 12-year-old child and then taking the organs out of that child in order to replace old tissues in an adult, right?
West: Right. What we are proposing as an ethical and moral use of cloning technology in the arena of human medicine is the creation of microscopic balls of cells, called blastocysts. These are aggregates of about 100 cells that exist up to about 14 days of development. At 14 days, small aggregations of cells begin to individualize. By that, we mean the cells begin to become the various cells and tissues of the body, or that they’ve committed themselves to become an individual human being. Prior to day 14, the small ball of cells can still become two individual human beings. They can become identical twins, and indeed that is how identical twins form: the small ball of cells divides into two. So prior to day 14, this small ball of cells has not individualized, it has not decided to become one individual or two individuals.

LEF: Or even any particular part of any individual.
West: Yes. There is no skin, there is no blood, there is no bone, there is no tissue of any kind. So, because they have not individualized, they have not committed to becoming a person. And because there is no person there, and there are no differentiated cells of any kind, the blastocyst is often called a pre-embryo to distinguish it from an embryo which is committed to becoming a given individual. And because of that primitive state of the cells, the majority of ethicists have agreed that the creation of such an aggregate of cells to benefit people who are sick and in need of therapy would be a good and moral use of technology.
So what we envision is that the cloning step, the nuclear transfer step, is a bit like a time machine. We believe we can take a cell from a patient, even from a very old patient, and put it back into an egg cell, and that egg cell would be like a time machine, taking what was once a skin cell back in time, making it young again and erasing its memory of what it was, taking it back to the state of complete power, or as we say, “totipotency,” such that the cell can then become any cell in the body. So once we’ve taken the cell back in time, and we have this small little ball of cells that can form anything, we can go in two directions. First, we could implant this small ball of cells into a uterus, and it could become a human being, or two human beings, forming identical twins. That would be reproductive cloning of a human being. The second path, which is the path that we are advocating, would be to use the cells to create specific cell types that a particular patient needs. So if the patient has Parkinson’s Disease, rather than creating a human being, we would create just the dopaminergic neurons that they have lost, the loss of which is causing their Parkinsonian symptoms.

LEF: But the pre-embryo, in and of itself, doesn’t spontaneously form wanted tissues. You would have to coax the pre-embryo cells to turn into the types of cells you want to form. Could you do that in tissue culture?
West: Yes. We believe that all of this could be done in tissue culture, growing individual cells, without creating a cloned human being.

LEF: What are embryonic stem cells?
West: Technically, an embryonic stem cell is a cultured inner cell mass. So the blastocyst is a little ball of cells, and inside it is a cluster of cells called the inner cell mass, and surrounding them is a shell of cells called the trophectoderm. The trophectoderm will become the placenta, and the inner cell mass will become the entire animal or, in the case of humans, the entire human being. The inner cell mass cells are totipotent. They have complete power. And because they have not yet committed to either becoming the germ line or the body (soma), they have not yet committed to the mortality of the soma, so they still have the immortality of the germ line. As you know, germ line cells have the ability of proliferating indefinitely, and that is why the species is immortal. We keep making babies generation after generation, so these cells are in this immortal germ line in a state of total power. When they are grown in the dish, they are called embryonic stem cells.

LEF: Has anyone taken these embryonic stem cells and turned them into specialized cells in tissue culture?
West: Yes.

LEF: Has this been published?
West: The first demonstration that human embryonic stem cells could be grown was published in the collaboration that I set up while I was at Geron with James Thomson at the University of Wisconsin at Madison, and then also in a collaboration with John Gearhart at Johns Hopkins University Medical School. That was in the Fall of 1998.

LEF: And what was done in this study, exactly?
West: It was the first time human embryonic stem cells were ever grown in vitro (“in the dish”). Also in this publication was evidence that they could be shown to differentiate into skin, neurons, heart muscle cells, blood cells, and all of the many different kinds of cells in the body.

LEF: But in that case, was the differentiation random, or was it directed in some way?
West: The initial work, of course, was random. The cells were either just allowed to haphazardly differentiate in the dish, or they were injected into mice which had an impaired immune system. Since the mice could not reject the human tissue inside them, the human cells grew into what is called a teratoma, which is a conglomeration of different kinds of cells and tissues.

LEF: We recently met a scientist who said he was able to transform skin cells into neurons. Our impression was that they weren’t embryonic skin cells.
West: They were probably adult stem cells such as mesenchymal stem cells.

LEF: So to summarize what you’ve said, basically you can take a totipotent cell and instead of letting it commit itself to form of an individual, you can take that cell and, at least in principle, direct it to become any type of cell. As you said, you can make brain cells to treat Parkinson’s disease or perhaps skin cells to treat facial aging, that sort of thing.
West: I think that is an accurate statement. A good example was reported just in the last couple of weeks or so. There was a paper where mouse embryonic stem cells were differentiated into beta islet cells. That is one of the more difficult examples. In normal embryological development, you are pretty far along before you get the gut, and then the gut evaginates into a pancreas, and then out of that pancreatic tissue a beta cell finally forms.

LEF: Yes, that is impressive.
West: It would be much easier to get, you know, a cardiac myocyte, which differentiates very early in embryogenesis, or neurons, or skin cells, but nevertheless they were able to develop embryonic stem cells into beta cells, isolate the beta cells in relatively pure form, and put them into a mouse and cure diabetes.

LEF: That’s fabulous!
West: Yes, and I think the demonstration that you could go and do such a difficult project is good evidence that there are going to be many, many applications of this technology.

LEF: Are you doing any work in the area of directing the differentiation of cells in your company?
West: Yes, though the majority of the work at Advanced Cell Technology has been focused on taking the cells back in time. It is relatively easy to take a cell at the beginning of life, one of these totipotent stem cells, and steer its development through the differentiated lineages, like the branches of the tree, because that’s the normal path of development. What’s almost miraculous is that you can take a differentiated cell and take it back to a totipotent state, because that’s taking differentiation in reverse. It’s a bit like if I were to tell you that I had taken a baseball bat and hit a ceramic vase and broken it into a million pieces on the floor, and then that I could, through a magic wand, have that go in reverse and have all of the pieces of the vase fly together and fuse back into a vase and then go back up on the table top, like reversing a video tape. That would be near miraculous. And to have development go in reverse, which it never does in nature, through cloning is pretty amazing, and that’s why the scientific community was so amazed that you could actually clone an animal from a body cell. But what I think is the second level of amazement is the fact that not only does the development go in reverse, but the animal is actually made young again in the process, and I think that’s what impressed us even more.

Bookmark and Share

7 Anti Aging Secrets

7 Anti Aging Secrets

1. DNA Life Changer

Healthy habits can actually repair your DNA, say researchers Dean Ornish, MD, and Elizabeth Blackburn, MD. Their study subjects ate vegetarian whole foods with 10 percent of calories from fat, walked 30 minutes six days a week, used stress-reducing techniques, and went to a weekly support group. The results? Besides a decrease in LDL cholesterol and stress levels, they showed a 29 percent rise in telomerase. This enzyme repairs and lengthens telomeres, tiny protein complexes on the ends of chromosomes that are vital for immunity and longevity. Short telomeres and low levels of telomerase signal an increased risk of heart disease and cancer, plus a poor prognosis if you do get ill.

Editor’s Note — October 5, 2009: Elizabeth H. Blackburn (mentioned below), Carol W. Greider and Jack W. Szostak have just won the Nobel Prize in Physiology or Medicine for their breakthrough work on telomerase, which was discussed in a Reader’s Digest article (see below) published earlier this year

2. Exercise Matters

A walk with your spouse gives you a chance to talk over the day, and playing tennis together can be a bonding experience. But that’s not why you should bother. Here’s why: Getting active can mean a longer life for both of you.

3. Two Important Steps to Remain Young From Dr. Oz

Walk. When you can’t walk a quarter mile in five minutes, your chance of dying within three years goes up dramatically.

Second most important is building a community — avoiding isolation. Because if your heart doesn’t have a reason to keep beating, it won’t.

4. Dial Back on Meat and Pork

A ten-year study of 545,000 Americans found that people who eat about four ounces of beef or pork a day (the amount in an average-sized burger) are at least 30 percent more likely to die early, compared with those who consume an ounce or less daily. Though previous research has linked a diet heavy in red meat to a greater risk of heart disease and colon cancer, this is the first big study to look at how it affects your life expectancy.

5. Two Keys to a Longer Life

Two recent studies suggest surprising but heartwarming keys to a longer life. You’re more likely to rack up the years if you:

Expect the best. Of 100,000 women in the Women’s Health Initiative study, those rated optimistic by special questionnaires were 14 percent less likely than pessimists to die during the study’s first eight years

Care for a loved one. Despite the stress involved, men and women who put in the most time taking care of a spouse cut their own risk of dying by 36 percent over a seven-year period, researchers at the University of Michigan in Ann Arbor found.

6. Get a Goal: Having a Purpose Gives You an Edge

Whether you believe you have some purpose to fulfill on earth or just have trips you plan to take and books you want to read, you have a survival edge over people with fewer goals. So say researchers at the Rush University Medical Center in Chicago who interviewed more than 1,200 older adults. Elders with sure intentions and goals were about half as likely as aimless seniors to die over the five-year follow-up.

7. Get Enough Vitamin D

Low vitamin D levels have been associated with osteoporosis, diabetes, hypertension, and cancer. And it gets worse: According to new research, adults who don’t get enough of the “sunshine vitamin” are 26 percent more likely to die early. A 12-year study of 13,000 men and women didn’t finger any one cause of death, “because vitamin D’s impact on health is so widespread,” says researcher Michal Melamed, MD, an assistant professor of medicine at Albert Einstein College of Medicine in the Bronx. Besides drinking fortified milk, she suggests that you: Get just 10 to 15 minutes of midday sunshine (11 a.m. to 3 p.m.) several days a week may do the trick (apply sunscreen after those few minutes). Take supplements.

Bookmark and Share

Tissue engineering and cell based therapies from the bench to the clinic: The potential to replace, repair and regenerate

Tissue engineering and cell based therapies from the bench to the clinic: The potential to replace, repair and regenerate

Reprod Biol Endocrinol. 2003; 1: 102.

William L Fodor

The field of Regenerative Biology as it applies to Regenerative Medicine is an increasingly expanding area of research with hopes of providing therapeutic treatments for diseases and/or injuries that conventional medicines and even new biologic drug therapies cannot effectively treat. Extensive research in the area of Regenerative Medicine is focused on the development of cells, tissues and organs for the purpose of restoring function through transplantation. The general belief is that replacement, repair and restoration of function is best accomplished by cells, tissues or organs that can perform the appropriate physiologic/metabolic duties better than any mechanical device, recombinant protein therapeutic or chemical compound. Several strategies are currently being investigated and include, cell therapies derived from autologous primary cell isolates, cell therapies derived from established cell lines, cell therapies derived from a variety of stem cells, including bone marrow/mesenchymal stem cells, cord blood stem cells, embryonic stem cells, as well as cells tissues and organs from genetically modified animals.

Continue reading

Bookmark and Share

Searching for Fountain of Youth in a Pill

By Brandon Keim

First stop, diabetes. Next stop: the very process of aging.

In a study scheduled to be published tomorrow in Nature, Sirtris Pharmaceuticals researchers successfully treated diabetic mice with a compound that activates an enzyme linked to the body’s most fundamental metabolic processes. Though preliminary, the results add momentum to a body of research that sees seemingly-disparate diseases, from diabetes to cancer, as manifestations of a single fundamental problem: age-related cellular breakdown. Slow that breakdown, and perhaps you can slow aging itself. It won’t ever stop, but it might not be attended by physical and mental failure.

“This is a watershed moment,” said Sirtris CEO Christoph Westphal. “It looks like you can control the proteins controlling the aging process with orally available drugs.”

The enzyme targeted in the Nature paper, called SIRT1, is believed to be stimulated by calorie-restricted diets, which are linked to longevity increases in primates and humans. Another SIRT1 activator, the grape leaf compound resveratrol, has increased lab animal lifespans and been used to treat diabetes and obesity in mice.

Thousands of people already practice caloric restriction, which requires incredible discipline and may cause unwanted metabolic changes. Thousands more take resveratrol, though the effects have yet to be rigorously studied. They’re willing to turn themselves into human guinea pigs or near-emaciated waifs because the benefits are so tantalizing. In the last few decades, some scientists and doctors have suggested that a range of lethal conditions have the same root: cellular deterioration that progresses with age.

More specifically, many scientists point to deterioration of mitochondria, the organelle power plants present in every cell of the human body. As mitochondria generate chemical energy — and help cells communicate, differentiate and grow – they spew out DNA-damaging free radicals. Over time, the mitochondria wear down; tissues malfunction and fail. The picture’s still hazy, the cause-and-effect not clear, but scientists have found evidence of mitochondrial degeneration in cancer, Parkinson’s disease, Alzheimer’s disease, diabetes, heart disease and a plethora of other conditions.

As described in the Nature paper, diabetic mice given Sirtris’ compound had improved insulin sensitivity and and lower blood glucose levels — and their mitochondria worked better, too. Rejuvenated mitochondria have also been observed in earlier studies of resveratrol’s therapeutic and longevity-enhancing effects.

It’s too soon to apply the results to people with diabetes, much less to people hoping to evade the ravages of dementia and debilitation — but the possibility is there. “Mechanistically, it’s fair to think that this will work in the biggest killers of western society. It’s one of the few approaches that could help with multiple diseases,” said Westphal.

He’s careful to point out that barely a tenth of all drugs survive from testing to approval, and the compound described in Nature isn’t even in Phase I trials. He’s also quick to distance Sirtris from off-label claims; this compound, as well as a resveratrol derivative currently in Phase I trials, are both aimed squarely at diabetes, and won’t be marketed as anything more.

But if people are willing to push ahead of science by taking resveratrol or practicing caloric restriction, they’ll certainly push to use a SIRT1-activating diabetes drug for other conditions. Neither is Sirtris the only player: every major pharmaceutical company, said Westphal, is pursuing research on the seven sirtuin enzymes. SIRT1 is but one of these, and all are linked to cellular regulation. “We’re trying to emphasize how many years and how much risk is involved,” he said. “But we’re at a different stage than we were five or ten years ago. There are people trying to develop drugs that target the aging process.”

Bookmark and Share